Many people in poor countries die from diseases that can easily be treated because they cannot afford the necessary medicine. I strongly believe that pharmaceutical companies should sell medicines at lower prices in these countries in order to save lives and improve public health.
One important reason is that many people in developing nations live in poverty and cannot pay for expensive treatment. Even common illnesses can become deadly if patients do not receive proper medication. For example, in remote areas of the Philippines, many villagers do not have access to affordable hospitals or pharmacies. As a result, some people die from treatable diseases simply because medicine is too expensive or unavailable.
In addition, drug companies earn huge profits in wealthier countries, so reducing prices for poorer nations would not seriously affect their business. In fact, offering cheaper medicine could improve their public image and help millions of people survive. Governments can also cooperate with pharmaceutical companies by creating policies that support low-cost medicine programs and improve healthcare services in rural areas.
Furthermore, international organizations could provide financial support to ensure that life-saving drugs reach people living in isolated communities. This would reduce the number of deaths caused by treatable illnesses and improve the quality of life in those countries.
In conclusion, drug companies should provide medicines at reduced prices in poor nations because healthcare should be accessible to everyone regardless of income. Combined with government support, this could save countless lives around the world